A Diagnostics & Imaging Week

Home Diagnostics (Fort Lauderdale, Florida), a manufacturer of diabetes testing supplies, reported reaching a settlement with Roche (Basel, Switzerland) regarding a patent infringement suit filed in 2004.

Roche had alleged that Home Diagnostics’ TrueTrack Smart System and TrackEASE Smart System blood glucose monitors infringed on U.S. Patent Nos. 5,366,609 and Re. 36,268, relating to biosensing blood glucose monitors.

Terms of the settlement include a paid-up worldwide license under the patents at issue, with amount paid by Home Diagnostics recorded as an expense in its 4Q07 financial results. In addition, the settlement terms include a covenant by Roche not to sue Home Diagnostics on the licensed patents.

In other legalities: Dilon Technologies (Newport News, Virginia) and Naviscan PET Systems (San Diego) said they have settled their lawsuit over Dilon’s medical imaging equipment.

Naviscan filed suit against Dilon in May in the U.S. District Court for the Southern District of California alleging patent infringement of six patents covering technology for detecting breast cancer.

Both sides were able to quickly resolve the matter, the companies said, and they “are hopeful that joint cooperation will be part of their futures as they seek to advance the fight against breast cancer.”

Dilon’s flagship product, the Dilon 6800, is a small field-of-view gamma camera for breast-specific imaging, a procedure that images the metabolic activity of breast lesions through radiotracer uptake.